Paid Clinical Trials Round Rock

Discover 435 paid clinical trials in Round Rock, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 435

LumateperoneMulticenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients

Recruiting

PHASE3

Sponsor:

Intra-Cellular Therapies, Inc.

Location:

Austin TX, Richmond TX, Houston TX, Frisco TXshow 38 more

Code:

NCT06372964

Conditions

Bipolar Depression

Eligibility Criteria

Sex: All

Age: 10 - 17

Healthy Volunteers: Not accepted

Interventions

Lumateperone

Placebo

PRAX-628An Open Label Trial to Evaluate the Efficacy and Safety of PRAX-628 in Adults With Focal Onset or Tonic-Clonic Seizures

Recruiting

PHASE2

Sponsor:

Praxis Precision Medicines

Location:

Round Rock TX, Seabrook TX, Chesterfield MO, Phoenix AZshow 4 more

Code:

NCT06908356

Conditions

Focal Onset Seizure

Primary Generalized Epilepsy

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

30mg PRAX-628

SPRINT® PNSThe MONARCH Case Series Study: SPRINT® Peripheral Nerve Stimulation for the Treatment of Head Pain

Recruiting

Sponsor:

SPR Therapeutics, Inc.

Location:

Round Rock TX, Cedar Park TX, Austin TX, San Marcos TXshow 6 more

Code:

NCT05491915

Conditions

Cervicogenic Headache

Occipital Neuralgia

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

SPRINT Peripheral Nerve Stimulation (PNS) System

Rilvegostomig & PembrolizumabA Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)

Recruiting

PHASE3

Sponsor:

AstraZeneca

Location:

Round Rock TX, Houston TX, Kingwood TX, Fort Worth TXshow 53 more

Code:

NCT06692738

Conditions

Non-small Cell Lung Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Rilvegostomig

Pembrolizumab

Carboplatin

Paclitaxel

Nab-paclitaxel

DupilumabEvaluation of Dupilumab in Patients With Atopic Keratoconjunctivitis (AKC)

Recruiting

PHASE2

Sponsor:

Andover Eye Associates

Location:

Round Rock TX, Pittsburg KS, Springfield MO, Memphis TNshow 16 more

Code:

NCT04296864

Conditions

Atopic Keratoconjunctivitis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Dupilumab

Macular EdemaA 2-part Study Consisting of a Multiple Ascending Dose Safety Study in Participants With Macular Edema Following Branch Retinal Vein Occlusion and a Dose-finding Safety and Preliminary Efficacy Study in Participants With Either Diabetic Macular Edema or Neovascular Age-related Macular Degeneration

Recruiting

PHASE1

PHASE2

Sponsor:

EyeBiotech Ltd.

Location:

Round Rock TX, Austin TX, San Antonio TX, The Woodlands TXshow 17 more

Code:

NCT06664502

Conditions

Diabetic Macular Edema (DME)

Neovascular Age-related Macular Degeneration (NVAMD)

BRVO - Branch Retinal Vein Occlusion

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

EYE201

Observational StudyUrinary Catheter Self-Discontinuation After Urogynecology Surgery

Recruiting

Sponsor:

University of Texas at Austin

Location:

Round Rock TX, Austin TX, Kyle TX

Code:

NCT05860634

Conditions

Urinary Retention

Pelvic Organ Prolapse

Stress Urinary Incontinence

Catheter Related Complication

Eligibility Criteria

Sex: Female

Age: 18+

Healthy Volunteers: Accepted

Interventions

Catheter self-discontinuation

VENT-02A Phase 1b Study of the NLRP3 Inhibitor VENT-02 in Patients With Mild to Moderate Parkinson's Disease

Recruiting

PHASE1

PHASE2

Sponsor:

Ventus Therapeutics U.S., Inc.

Location:

Round Rock TX, Cypress TX, Memphis TN, Englewood COshow 18 more

Code:

NCT06822517

Conditions

Parkinson Disease

Eligibility Criteria

Sex: All

Age: 45 - 70+

Healthy Volunteers: Not accepted

Interventions

VENT-02

Placebo

MBX 2109Extension Study to Evaluate the Long-Term Safety and Tolerability of MBX 2109 in Patients With Hypoparathyroidism

Recruiting

PHASE2

Sponsor:

MBX Biosciences

Location:

Round Rock TX, San Antonio TX, Fort Worth TX, Dallas TXshow 17 more

Code:

NCT06531941

Conditions

Hypoparathyroidism

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

400 µg of MBX 2109 once-weekly by subcutaneous injection

200-1600 µg of MBX 2109 once-weekly by subcutaneous injection

IptacopanA Phase III Study to Investigate Efficacy, Safety and Tolerability of Iptacopan Compared With Placebo in Participants Aged 18 to 75 Years With gMG.

Recruiting

PHASE3

Sponsor:

Novartis Pharmaceuticals

Location:

Round Rock TX, Nashville TN, Springfield IL, Scottsdale AZshow 9 more

Code:

NCT06517758

Conditions

Generalized Myasthenia Gravis

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Iptacopan

Matching Placebo